CSI Market
Sign In | Register

Calidi Biotherapeutics Inc (CLDI) Annual Balance Sheets

Annual · GAAP · USD millions
Access CLDI quarterly Balance Sheets →
From Calidi Biotherapeutics Inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent5.60
Cash & Short-term Investments5.00
Accounts receivable0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.66
Total Current Assets6.26
Equipment/Property/Plant Net0.78
Derivative Asset, Noncurrent DE10.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Other Assets, Noncurrent1.82
Operating Lease Right Of Use Asset1.68
Total Assets8.86
Liabilities
Accounts Payable, Current AC0.60
Accrued Liabilities, Current AC1.28
Financial Instruments0.00
Loans Payable, Current NO0.00
Other Liabilities, Current2.06
Total Current Liabilities3.94
Long-term debt0.00
Total Long-term Debt0.00
Financial Instruments, Insurance, Noncurrent0.00
Other liabilities, Noncurrent1.16
Finance Lease Liability Current0.11
Operating Lease Liability Current1.41
Derivative Liabilities Non Current One-
Deferred Underwriting Fees Payable Non Current-
Total Liabilities5.10
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock145.39
Retained Earnings / Accumulated Deficit-141.62
Other Equity0.14
Common Stockholder's Equity3.92
Non-controlling interests & other0.00
Total Stockholder's Equity3.76
Liabilities & Stockholder's Equity8.86
4 historic quarters locked

Sign in to unlock the full Calidi Biotherapeutics Inc balance sheet history.

Sign In Create Free Account

About Calidi Biotherapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 27, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013242

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.